High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity is a research paper published in PLoS ONE (2021). On theSindex it has a DataRank of 1.6. It has been cited 49 times, with 41 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.587
From this paper's citation signal
Citation Network Contribution
0.996
From 34 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 41 citers.
National Institute of Allergy and Infectious Diseases
Grant: HHSN272201700059C
National Institute of Allergy and Infectious Diseases
Grant: 75N93019D00021
National Institute of Allergy and Infectious Diseases
Grant: 75N93020P00667
Biological and Environmental Research
Grant: DE-AC05-76RL01830
ORFDO NIH HHS
Grant: 75N99019D00021
NIAID NIH HHS
Grant: 75N93021D00021
CLC NIH HHS
Grant: 75N90019D00021
Coronavirus CARES Act
MeSH Terms